Growing disparities: an analysis of equity in China’s oncology clinical trials relative to disease burden (2014–2023)
Journal of Global Health · 20.11.2026 · 16
DOI: 10.7189/jogh.16.04316 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Global Health, online erschienen am 20.11.2026. Verfasst von Jiaxin Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China. Hauptthemen laut MEDLINE: Clinical Trials as Topic, Neoplasms, Cost of Illness, Medical Oncology. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
- International Research Center for Medicinal Administration, Peking University, Beijing, China.
Zitieren
APA
Huang, J., Li, W., Li, X., Shi, L., & Chen, J. (2026). Growing disparities: an analysis of equity in China’s oncology clinical trials relative to disease burden (2014–2023). Journal of Global Health, 16. https://doi.org/10.7189/jogh.16.04316
Vancouver
Huang J, Li W, Li X, Shi L, Chen J. Growing disparities: an analysis of equity in China’s oncology clinical trials relative to disease burden (2014–2023). Journal of Global Health. 2026;16. doi:10.7189/jogh.16.04316
BibTeX
@article{Huang2026,
author = {Huang, Jiaxin and Li, Weimiao and Li, Xiaoyu and Shi, Luwen and Chen, Jing},
title = {Growing disparities: an analysis of equity in China’s oncology clinical trials relative to disease burden (2014–2023)},
journal = {Journal of Global Health},
year = {2026},
volume = {16},
doi = {10.7189/jogh.16.04316}
}
EUVIMED